Focusing on regulatory filings and accelerating U.S. commercialization efforts Contract of up to $155 million with BARDA for U.S. stockpiling continues to advance Dijon, France February 6, 2024.
Crossject provides strategic update on priorities for 2024 finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
Dijon, France, February 1, 2024 18:15 CET - Crossject , a specialty pharma company developing needle-free auto-injectors for emergency situations, will hold a conference call on its commercial.